– 1. Wang H, Shang Y, Wang E, et al. MST1 mediates neuronal loss and cognitive deficits: A novel therapeutic target for Alzheimer’s disease. Progress in Neurobiology. 2022: 102280
2. Yang L, Li N, Yang D, et al. CCL2 regulation of MST1-mTOR-STAT1 signaling axis controls BCR signaling and B-cell differentiation. Cell Death & Differentiation. 2021: 1-18
3. Zhu Y, Gu H, Yang L, et al. Involvement of MST1/mTORC1/STAT1 activity in the regulation of B-cell receptor signalling by chemokine receptor 2. Clinical and Translational Medicine. 2022, 12(7): e887.
4. Shang Y, Yan Y, Chen B, et al. Over‐expressed MST1 impaired spatial memory via disturbing neural oscillation patterns in mice. Genes, Brain and Behavior. 2020: e12678
5. Xu W, Shi Z, Yu X, et al.Salvianolic acid B exerts an anti-hepatocellular carcinoma effect by regulating the Hippo/YAP pathway and promoting pSmad3L to pSmad3C simultaneously.European Journal of Pharmacology.2022: 175423.
6. Lin G, Xia A, Qiao J, et al.Identification of a new class of activators of the Hippo pathway with antitumor activity in vitro and in vivo.Biochemical Pharmacology.2024: 116217.
7. Zhu C, Zheng R, Han X, et al.Knockout of integrin αvβ6 protects against renal inflammation in chronic kidney disease by reduction of pro-inflammatory macrophages.Cell Death & Disease.2024, 15(6): 397.
8. Effects of YAP Inhibitors and Activators on the Growth of Leukemia Cells[J]. Anticancer Research, 2025, 45(3): 977-987.